Top 5 Low Price Stocks To Invest In Right Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Nokia (NYSE: NOK  ) have gotten clobbered today, down by as much as 12% after the Finnish smartphone maker reported first-quarter earnings.

So what: Revenue in the first quarter totaled $7.7 billion, which missed the Street's forecasts. On the bright side, the company narrowed its loss to $0.07 per share. There was other good news, as Lumia shipments were strong and increased 27% sequentially to 5.6 million units. Nokia closed the quarter with $5.9 billion in net cash.

Now what: Total smartphones dropped precipitously as Nokia expectedly ramps down Symbian units, which were just 500,000. The company's Asha line of feature phones saw shipments of 5 million. Nokia's lower-end devices are under competitive pressure from Android devices targeting low price points. The networks business held up, and CEO Stephen Elop said that segment helped contribute to Nokia's cash position this quarter. However, investors were focusing on the weakness up top.

5 Best Dow Dividend Stocks To Invest In Right Now: Cubist Pharmaceuticals Inc.(CBST)

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), a once-daily, bactericidal, intravenous, antibiotic with activity against gram-positive organisms, including methicillin-resistant staphylococcus aureus. Its clinical development product pipeline consists of CXA-201, which is in the phase III clinical trial for patients with complicated urinary tract infections; and in phase II clinical trial for patients with complicated abdominal infections. The company is also developing CXA-201 for the treatment of hospital acquired pneumonia. In addition, its product under development comprises CB-183,315, an oral, bactericidal lipopeptide with in vitro bactericidal activity against C. difficile, for the treatment of clostridium difficile-associated diarrhea (CDAD). Further , the company?s pre-clinical programs include therapies to treat various bacterial infections and agents to treat acute pain. Additionally, it promotes MERREM I.V. (meropenem for injection), a carbapenem class intravenous antibiotic, in the United States under a commercial services agreement with AstraZeneca Pharmaceuticals, LP; and DIFICID as the treatment for CDAD in adults under the co-promotion agreement with Optimer Pharmaceuticals, Inc. The company also has collaborations with Forma Therapeutics, Inc. to discover and develop antibacterial compounds; an agreement with the Broad Institute to transform natural products discovery; a collaboration with Hydra Biosciences, Inc., to develop ion channel drugs; and a collaboration agreement with Alnylam Pharmaceuticals, Inc., for the development and commercialization of Alnylam's RNAi therapeutics as a therapy for the treatment of respiratory syncytial virus. The company was founded in 1992 and is headquartered in Lexington, Mas sachusetts.

Advisors' Opinion:

• [By Lee Jackson]

  Cubist Pharmaceuticals Inc. (NASDAQ: CBST) is another top stock to buy making acquisitions. It recently received antitrust clearance for its�purchase of Trius Pharmaceutical. The acquisition strengthens its already strong antibiotic franchise. UBS has a $70 price target, and the consensus is placed at $65.

• [By Sean Williams]

  What: Shares of Cubist Pharmaceuticals (NASDAQ: CBST  ) , a biopharmaceutical company devoted to developing acute care therapies, added 12% following the announcement of its second-quarter earnings results.

Top 5 Low Price Stocks To Invest In Right Now: Rallye SA (RAL)

Rallye SA is a France-based holding company organized around two sectors of activity: large scale distribution to the food stores and supermarkets and distribution of sports items. The Company is present in France, Latin America, Poland, and Asia through its interests in brands, such as Geant, Monoprix, Leader Price, and United Grocers Cash & Carry, among others. It also has its interst in the Groupe Go Sport. Rallye SA is notably present in France, the United States, Luxembourg, Poland and Colombia, among others. The Company operates through its subsidiaries and affliated companies, such as Cobivia SAS, L��abitation Moderne de Boulogne, Magasins Jean SAS, Matignon Sablons SAS, MFD SA, Parande SAS, Casino Guichaqrd Perrachon DA, Groupe Go Sport, Sivigral SCI and French Develompent Venture SA. Advisors' Opinion:

• [By Holly LaFon]

  A risk involved with the company is that its Republic Bank & Trust business derives 78% of its net income from TRS, which offers bank products that help get customers who electronically file their tax returns their payments. RB&T is only of the few financial institutions in the U.S. that provide the service. Under the program, the taxpayer may receive a Refund Anticipation Loan (RAL), which has been questioned by various governmental and consumer groups. In May 2011, RB&T received an order to cease and desist which could result in an order by the FDIC to terminate its RAL program. It has a hearing on Feb. 12, 2012 in Kentucky regarding the matter.

Top 5 Low Price Stocks To Invest In Right Now: Companhia de Bebidas das Americas - AmBev(ABV)

Companhia de Bebidas das Americas?Ambev engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt, and other non-alcoholic and non-carbonated products in the Americas. It also sells bottled water, isotonics, and ready-to-drink teas. The company provides its products under the brand names of Skol, Brahma, Antarctica, Guarana Antarctica, Gatorade, Brahva, Brahva Beats, Extra, Brahma Light, Brahma Ice, Quilmes, Stella Artois, Red Rock, Pepsi-Cola, Seven UP, Zenda, Concordia, Triple Kola, Quilmes Cristal, Brahma, Andes, Pacena, Taquina, Huari, Becker, Baltica, Pilsen, Patricia, Labatt Blue, Alexander Keith?s, and Kokanee. It has a licensing agreement with Anheuser-Busch, Inc. to produce, bottle, distribute, and sell Budweiser products in Canada and Paraguay. Companhia de Bebidas das Americas?Ambev distributes its products through direct distribution system and third-party distributors. The company was founded in 1888 and is headquarter ed in Sao Paulo, Brazil. Companhia de Bebidas das Americas?Ambev is a subsidiary of Interbrew International B.V.

Advisors' Opinion:

• [By Robert Martin]

  South Africa, China, Mexico and Brazil collectively make up 68% of ECON�� holdings. The top three holdings are Naspers LTD (NPSNY) at 10%, AmBev (ABV) at 8% and FEMSA (FMX) at 5.6%.

• [By Dividend]

  Companhia de Bebidas Das Americas (ABV) has a market capitalization of $118.32 billion. The company employs 51,299 people, generates revenue of $14.120 billion and has a net income of $4.662 billion. Companhia de Bebidas Das Americas�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.829 billion. The EBITDA margin is 48.36 percent (the operating margin is 43.00 percent and the net profit margin 33.02 percent).

• [By Hilary Kramer]

  Companhia de Bebidas das Americas (ABV): Better known as Ambev, it is one of the largest brewers in the world and the largest in Latin America (in terms of sales volume). It makes a variety of beverages, including beer and soft drinks, and is also one of the biggest independent PepsiCo bottlers in the world. The company has done a good job lately of emphasizing premium beers, which carry a higher margin, to offset recent lower sales volumes. ABV yields a solid 4.6%.

Top 5 Low Price Stocks To Invest In Right Now: Health Management Associates Inc.(HMA)

Health Management Associates, Inc., through its subsidiaries, engages in the operation of general acute care hospitals and other health care facilities in non-urban communities in the United States. Its hospitals provide services, including general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, and pediatric services. The company also offers outpatient services, such as one-day surgery, laboratory, x-ray, respiratory therapy, cardiology, and physical therapy. In addition, its hospitals provide specialty services in cardiology, neuro-surgery, oncology, radiation therapy, computer-assisted tomography scanning, magnetic resonance imaging, lithotripsy, and full-service obstetrics. As of December 31, 2011, the company operated 66 hospitals with a total of 10,330 licensed beds in non-urban communities in Alabama, Arkansas, Florida, Georgia, Kentucky, Mississippi, Missouri, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Washington, and West Virginia. Health Management Associates was founded in 1977 and is based in Naples, Florida.

Advisors' Opinion:

• [By Jeff Reeves]

  UnitedHealth�(UNH), Aetna�(AET) and WellPoint�(WLP) — the three largest managed-care insurers, as measured by market capitalization — are all up more than 30% year-to-date to outperform the S&P 500. And hospital operators like Health Management Associates (HMA) and Universal Health Services (UHS) are up big this year, too.

• [By Dan Caplinger]

  That in turn could create a problem for hospital companies. Tenet Healthcare (NYSE: THC  ) , Community Health Systems (NYSE: CYH  ) , and Health Management Associates (NYSE: HMA  ) have all seen their share prices jump sharply as investors grow increasingly excited about the prospects of uninsured Americans getting mandated coverage under Obamacare. The hope is that by having more people insured, these hospital companies will lose less in uncovered health care expenses they incur when they treat uninsured patients.

• [By Brad Thomas]

  As the only healthcare REIT with a "hospital-focused" platform, MPW is a relatively new REIT that was formed (in 2004) to lease from many of the nation's leading hospital operators, including Prime Healthcare Services, Kindred Healthcare (KND), HealthSouth (HLS), Health Management Associates (HMA), Community Health Systems (CYH), Vibra Healthcare, Ernest Health Inc., and IASIS Healthcare.